Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012
- PMID: 27554477
- PMCID: PMC5398392
- DOI: 10.4143/crt.2016.129
Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012
Abstract
Purpose: Malignant central nervous system (CNS) germ cell tumors (GCTs), although rare, are thought to occur more frequently among Asians. However, a recent population-based study revealed no differences in GCT incidence between Asians and Caucasians. Therefore, this study was conducted to determine the incidence and survival rates of CNS GCTs using the national cancer incidence database, and to compare these rates to those in the United States and Japan.
Materials and methods: We extracted CNS GCT patients diagnosed between 2005 and 2012 from the Korea Central Cancer Registry database. Age-standardized rates (ASRs), annual percentage change, and the male-female incidence rate ratios (IRRs) were calculated. To estimate the survival rate, we used data for patients diagnosed between 2005 and 2010 and followed their cases until December 31, 2013.
Results: The ASR for CNS GCT between 2005 and 2012 was 0.179 per 100,000 (95% confidence interval, 0.166 to 0.193), with an overall male-to-female (M:F) IRR of 2.95:1. However, when stratified by site, the M:F IRR was 13.62:1 for tumors of the pineal region and 1.87:1 for those located in nonpineal regions. The most frequent histologic type was germinoma (76.0%), and the most frequent location was the suprasellar region (48.5%). The 5-year survival rate of germinoma patients was 95.3%.
Conclusion: The incidence rate of CNS GCTs in Korea during 2005-2012 was 0.179 per 100,000, which was similar to that of the Asian/Pacific Islander subpopulation in the United States. Moreover, the CNS GCT survival rate in Korea was similar to rates in Japan and the United States.
Keywords: Central nervous system; Germ cell tumor; Incidence; Korea; Survival.
Conflict of interest statement
Conflict of interest relevant to this article was not reported.
Figures
Similar articles
-
Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.J Neurooncol. 2019 Jun;143(2):251-260. doi: 10.1007/s11060-019-03173-4. Epub 2019 Apr 25. J Neurooncol. 2019. PMID: 31025275
-
Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries.Neuro Oncol. 2012 Sep;14(9):1194-200. doi: 10.1093/neuonc/nos155. Epub 2012 Aug 6. Neuro Oncol. 2012. PMID: 22869621 Free PMC article.
-
Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysis.Neuro Oncol. 2010 Mar;12(3):257-64. doi: 10.1093/neuonc/nop029. Epub 2009 Dec 21. Neuro Oncol. 2010. PMID: 20167813 Free PMC article.
-
Primary CNS germ cell tumors: current epidemiology and update on treatment.Med Oncol. 2013 Jun;30(2):496. doi: 10.1007/s12032-013-0496-9. Epub 2013 Feb 24. Med Oncol. 2013. PMID: 23436013 Review.
-
Update on current standard treatments in central nervous system germ cell tumors.Curr Opin Neurol. 2010 Dec;23(6):571-5. doi: 10.1097/WCO.0b013e32833ff522. Curr Opin Neurol. 2010. PMID: 20885323 Review.
Cited by
-
Pediatric sellar teratoma - Case report and review of the literature.Childs Nerv Syst. 2024 Apr;40(4):1259-1270. doi: 10.1007/s00381-024-06296-w. Epub 2024 Jan 26. Childs Nerv Syst. 2024. PMID: 38276973 Free PMC article. Review.
-
Effect of delayed diagnosis on neuroendocrine function in individuals with suprasellar germ cell tumors.Front Endocrinol (Lausanne). 2024 Jun 18;15:1408065. doi: 10.3389/fendo.2024.1408065. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38957439 Free PMC article.
-
[Diagnosis of germ cell tumors].Radiologie (Heidelb). 2023 Aug;63(8):598-602. doi: 10.1007/s00117-023-01172-1. Epub 2023 Jul 5. Radiologie (Heidelb). 2023. PMID: 37405483 Review. German.
-
The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis.Eur J Med Res. 2023 Jan 20;28(1):39. doi: 10.1186/s40001-023-01011-y. Eur J Med Res. 2023. PMID: 36670466 Free PMC article.
-
Long-Term Outcomes and Sequelae Analysis of Intracranial Germinoma: Need to Reduce the Extended-Field Radiotherapy Volume and Dose to Minimize Late Sequelae.Cancer Res Treat. 2021 Oct;53(4):983-990. doi: 10.4143/crt.2020.1052. Epub 2021 Jan 13. Cancer Res Treat. 2021. PMID: 33494128 Free PMC article.
References
-
- Thakkar JP, Chew L, Villano JL. Primary CNS germ cell tumors: current epidemiology and update on treatment. Med Oncol. 2013;30:496. - PubMed
-
- Oi S, Matsuzawa K, Choi JU, Kim DS, Kang JK, Cho BK. Identical characteristics of the patient populations with pineal region tumors in Japan and in Korea and therapeutic modalities. Childs Nerv Syst. 1998;14:36–40. - PubMed
-
- Makino K, Nakamura H, Yano S, Kuratsu J, Kumamoto Brain Tumor Research Group Incidence of primary central nervous system germ cell tumors in childhood: a regional survey in Kumamoto prefecture in southern Japan. Pediatr Neurosurg. 2013;49:155–8. - PubMed
-
- Kuratsu J, Takeshima H, Ushio Y. Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int J Clin Oncol. 2001;6:183–91. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources